XML 50 R38.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Compensation (Tables)
9 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement [Abstract]  
Compensation Expense Information
The following table provides information regarding our stock-based compensation:
Three Months Ended December 31, Nine Months Ended December 31,
(In thousands)2020201920202019
Pre-tax share-based compensation costs charged against income$1,588 $1,780 $5,944 $5,682 
Income tax benefit recognized on compensation costs$263 $275 $826 $886 
Total fair value of options and RSUs vested during the period$— $465 $6,796 $7,830 
Cash received from the exercise of stock options$39 $463 $1,324 $1,007 
Tax benefits realized from tax deductions resulting from RSU issuances and stock option exercises$15 $105 $963 $587 
Summary of Restricted Shares A summary of the RSUs granted under the 2005 Plan and the 2020 Plan is presented below:
 
 
 
RSUs
 
Shares
(in thousands)
Weighted
Average
Grant-Date
Fair Value
Nine Months Ended December 31, 2019
Vested and unvested at March 31, 2019413.0 $36.58 
Granted220.3 31.02 
Vested and issued(73.0)47.68 
Forfeited(34.2)35.97 
Vested and unvested at December 31, 2019526.1 32.74 
Vested at December 31, 2019138.3 31.71 
   
Nine Months Ended December 31, 2020
Vested and unvested at March 31, 2020512.1 $32.49 
Granted179.7 39.82 
Vested and issued(74.0)44.38 
Forfeited(4.7)56.11 
Vested and unvested at December 31, 2020613.1 33.02 
Vested at December 31, 2020150.4 31.98 
Fair Value of Options Granted
The fair value of each award is estimated on the date of grant using the Black-Scholes Option Pricing Model that uses the assumptions presented below:
 Nine Months Ended December 31,
 2020 2019
Expected volatility
32.1% - 32.2%
 
30.9% - 31.3%
Expected dividends$—  $— 
Expected term in years
6.0 to 7.0
 
6.0 to 7.0
Risk-free rate0.5 % 
2.3% to 2.4%
Weighted average grant date fair value of options granted$12.91 $10.83 
Stock Option Activity
A summary of option activity under the 2005 Plan and the 2020 Plan is as follows:
 
 
 
 
Options
 
 
Shares
(in thousands)
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value
(in thousands)
Nine Months Ended December 31, 2019
Outstanding at March 31, 2019944.6 $38.45 
Granted302.7 30.53 
Exercised(36.0)27.96 
Forfeited or expired(155.3)41.18 
Outstanding at December 31, 20191,056.0 36.14 6.9$9,035 
Vested at December 31, 2019602.0 38.90 5.4$4,756 
Nine Months Ended December 31, 2020    
Outstanding at March 31, 20201,020.2 $35.90 
Granted249.9 39.98 
Exercised(65.8)20.14 
Forfeited or expired— — 
Outstanding at December 31, 20201,204.3 37.61 6.8$3,987 
Vested at December 31, 2020696.2 39.50 5.4$2,786